Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of GSK1838262 extended release
tablets in the treatment of patients with Restless Legs Syndrome and associated sleep
disturbance.